A detailed history of Dock Street Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Dock Street Asset Management Inc holds 11,027 shares of ABT stock, worth $1.15 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
11,027
Previous 14,583 24.38%
Holding current value
$1.15 Million
Previous $1.61 Million 21.93%
% of portfolio
0.19%
Previous 0.25%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 23, 2024

SELL
$109.52 - $120.96 $389,453 - $430,133
-3,556 Reduced 24.38%
11,027 $1.25 Million
Q4 2023

Jan 31, 2024

SELL
$90.19 - $110.4 $2,886 - $3,532
-32 Reduced 0.22%
14,583 $1.61 Million
Q2 2023

Jul 25, 2023

SELL
$100.78 - $112.29 $71,049 - $79,164
-705 Reduced 4.6%
14,615 $1.59 Million
Q4 2022

Jan 24, 2023

SELL
$95.06 - $111.52 $77,949 - $91,446
-820 Reduced 5.08%
15,320 $0
Q1 2022

Apr 14, 2022

SELL
$114.02 - $139.04 $110,485 - $134,729
-969 Reduced 5.66%
16,140 $1.91 Million
Q1 2021

Apr 15, 2021

SELL
$108.84 - $128.23 $3,482 - $4,103
-32 Reduced 0.19%
17,109 $2.05 Million
Q4 2020

Jan 27, 2021

BUY
$105.0 - $114.42 $114,240 - $124,488
1,088 Added 6.78%
17,141 $1.88 Million
Q2 2020

Jul 22, 2020

SELL
$76.57 - $98.0 $22,588 - $28,910
-295 Reduced 1.8%
16,053 $1.47 Million
Q4 2019

Jan 29, 2020

SELL
$78.51 - $87.4 $4,004 - $4,457
-51 Reduced 0.31%
16,348 $1.42 Million
Q2 2019

Jul 31, 2019

SELL
$72.88 - $85.0 $868,000 - $1.01 Million
-11,910 Reduced 42.07%
16,399 $1.38 Million
Q1 2018

Apr 24, 2018

SELL
$56.27 - $63.62 $670,794 - $758,414
-11,921 Reduced 29.63%
28,309 $1.7 Million
Q4 2017

Jan 29, 2018

BUY
$53.68 - $57.47 $11,219 - $12,011
209 Added 0.52%
40,230 $2.3 Million
Q3 2017

Oct 17, 2017

BUY
$48.06 - $53.64 $1.92 Million - $2.15 Million
40,021
40,021 $2.14 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dock Street Asset Management Inc Portfolio

Follow Dock Street Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dock Street Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dock Street Asset Management Inc with notifications on news.